ENTITY

Soligenix (SNGX US)

25
Analysis
Health Care • United States
Soligenix, Inc. develops therapeutics and vaccines. The Company researches treatments for gastrointestinal Graft-versus-Host disease and cancer, and develops vaccines for military and civilian applications.
more
Exchange Announcement • 29 May 2026 05:21
Exchange Announcement • 29 May 2026 05:20
Exchange Announcement • 09 May 2026 04:16
Exchange Announcement • 09 May 2026 04:14
Exchange Announcement • 09 May 2026 04:12
x